Mayne Pharma Group Ltd has released a press release.
Outcome of litigation and update on Scheme
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- MYX announces PBS listing of NEXTSTELLIS in Australia
- Mayne Pharma addresses recent media articles regarding FIRB
- 2025 Full Year Results Investor Presentation
- 2025 Full Year Results Media Release
- Full Year Statutory Accounts
Later from Mayne Pharma
- MYX Scheme of Arrangement update on FIRB approval
- Update on Scheme and Supreme Court of NSW proceedings
- MYX - Panel Conducts Proceedings and Makes Interim Orders
- Update on FIRB approval and Scheme
- MYX Declaration of Unacceptable Circumstances and Orders
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma